ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned
- S. Viviani
- P.L. Zinzani
- A. Rambaldi
- E. Brusamolino
- A. Levis
- V. Bonfante
- U. Vitolo
- A. Pulsoni
- A.M. Liberati
- G. Specchia
- P. Valagussa
- A. Rossi
- F. Zaja
- E.M. Pogliani
- P. Pregno
- M. Gotti
- A. Gallamini
- D. Rota Scalabrini
- G. Bonadonna
- A. Gianni
DOIAbstract
BEACOPP, an intensified regimen consisting of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone, has been advocated as the new standard of treatment for advanced Hodgkin's lymphoma, in place of the combination of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD
Add to ORKG